Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating agents alone or in combination with Venetoclax
Candoni, Anna, Lazzarotto, Davide, Papayannidis, Cristina, Piccini, Matteo, Nadali, Giampaolo, Dargenio, Michelina, Riva, Marta, Fracchiolla, Nicola, Mellillo, Lorella, Dragonetti, Giulia, Del Principe, Maria Ilaria, Cattaneo, Chiara, Stulle, Manuela, Pasciolla, Crescenza, De Marchi, Roberta, Delia, Mario, Tisi, Maria Chiara, Bonuomo, Valentina, Sciumè, Mariarita, Spadea, Antonio, Sartor, Chiara, Griguolo, Davide, Buzzatti, Elisa, Basilico, Claudia Maria, Sarlo, Chiara, Piccioni, Anna Lina, Cerqui, Elisa, Lessi, Federica, Olivieri, Attilio, Fanin, Renato, Luppi, Mario, Pagano, Livio
Published in American journal of hematology (01.04.2023)
Published in American journal of hematology (01.04.2023)
Get full text
Journal Article